On December 7, 2020, Kenota Health announced it has raised $11 million in financing to support its point-of-care allergy testing. Kenota’s initial seed financing round of $2 million was followed by a $9 million Series A led by Draper Associates, totaling $11 million in funding. The funding will be used to provide rapid and reliable allergy testing and will enable physicians to test and treat more patients in a single clinic visit.
Kenota Health is a Waterloo based medical technology company focused on improving healthcare through data and testing. Kenota is focused on providing a new approach to allergy testing which takes less than 30 minutes to test for a patient’s allergic sensitizations.
Osler, Hoskin & Harcourt LLP advised Kenota Health with a team consisting of Chad Bayne, Gary Marshall and Theresa Donkor (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Partner, Emerging and High Growth Companies, Toronto
